M. Proesmans (Leuven, Belgium), S. Unger (Edinburgh (Edinburgh), United Kingdom)
This session is built from abstracts published on the ERS Congress platform from 23 August, in a PowerPoint format with a pre-recorded audio narration. The live session is scheduled from September 5-7 and each presenter will have a 5-minutes live, slide show presentation followed at the end of the session by 30-minutes general discussion.
Implementation of a Paediatric Bronchiectasis Severity Index (PBSI)
N. Parsons (Birmingham, United Kingdom), P. Kenia (Birmingham, United Kingdom), H. Smith (Birmingham, United Kingdom), P. Nagakumar (Birmingham, United Kingdom)
|    |
Chronic wet cough in Australian children: societal costs and quality of life
S. Prime (Brisbane, Australia), H. Carter (Brisbane, Australia), S. Mcphail (Brisbane, Australia), H. Petsky (Brisbane, Australia), A. Chang (Darwin, Australia), N. Graves (Singapore, Singapore), J. Marchant (Brisbane, Australia)
| |
Pseudomonas aeruginosa isolation in respiratory samples of children with neurological impairment- does it matter?
K. Wilkinson (Leicester, United Kingdom), R. Devaney (Leicester, United Kingdom), B. Elkington (Leicester, United Kingdom), I. Ahmed (Leicester, United Kingdom), H. Hickey (Leicester, United Kingdom), L. Mogford (Leicester, United Kingdom), A. Karthik (Leicester, United Kingdom), K. Jain (Leicester, United Kingdom)
| |
Pulmonary function in children previously treated with empyema
M. Senturk (Istanbul, Turkey), Y. Gokdemir (Istanbul, Turkey), P. Ergenekon (Istanbul, Turkey), C. Yilmaz Yegit (Istanbul, Turkey), M. Cenk (Istanbul, Turkey), M. Kalyoncu (Istanbul, Turkey), A. Guliyeva (Istanbul, Turkey), A. Bakir (Istanbul, Turkey), G. Kiyan (Istanbul, Turkey), F. Karakoc (Istanbul, Turkey), E. Erdem Eralp (Istanbul, Turkey), S. Girit Kanmis (Istanbul, Turkey), E. Atag (Istanbul, Turkey), S. Geylani Gulec (Istanbul, Turkey), B. Karadag (Istanbul, Turkey)
| |
Palivizumab: Is it cost effective to extend the vaccination period for patients at risk of severe respiratory syncytial virus infection?
G. Wilson (Stevenage, United Kingdom), L. Selby (Cambridge, United Kingdom), P. Desai (Ipswich, United Kingdom)
| |
Severity Scores used in the assessment of Bronchiolitis: A systematic review
W. Bedson (Liverpool, United Kingdom), E. Wilkinson (Liverpool, United Kingdom), D. Hawcutt (Liverpool, United Kingdom), P. Mcnamara (Liverpool, United Kingdom)
| |
Structured Light Plethysmography (SLP) in COVID-19 children: a focus on Multisystem Inflammatory Syndrome in Children (MIS-C)
E. Longoni (Milano, Italy), M. Pascuzzi (Milano, Italy), F. Riccaboni (Milano, Italy), M. Sartorio (Milano, Italy), M. Ghezzi (Milano, Italy), A. Farolfi (Milano, Italy), M. Piazza (Verona, Italy), L. Tenero (Verona, Italy), G. Piacentini (Verona, Italy), E. D'Auria (Milano, Italy), G. Zuccotti (Milano, Italy)
| |
Widespread use of face masks and respiratory viral infections: the SARS-CoV-2 pandemic lesson
L. Matera (Rome, Italy), R. Nenna (Rome, Italy), A. Frassanito (Rome, Italy), L. Petrarca (Rome, Italy), E. Mancino (Rome, Italy), G. Di Mattia (Rome, Italy), D. La Regina (Rome, Italy), V. Rizzo (Rome, Italy), C. Tonnarini (Rome, Italy), F. Midulla (Rome, Italy)
| |
Late Breaking Abstract - Impact of COVID-19 social distancing on viral infection in France: a delayed outbreak of RSV
C. Delestrain (Creteil, France), K. Danis (St Maurice, France), I. Hau (St Maurice, France), S. Behillil (Paris, France), M. Billard (Utrecht, Netherlands), L. Kragten (Zeist, Netherlands), R. Cohen (Creteil, France), B. Louis (Utrecht, Netherlands), R. Epaud (Creteil, France)
| |
Discussion
| |